Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08MCS
|
|||
| Drug Name |
ADS-5102
|
|||
| Synonyms |
Amantadine hydrochloride; 1-Adamantanamine hydrochloride; 665-66-7; 1-Aminoadamantane hydrochloride; Amantadine HCl; Mydantane; Midantan; Midantane; Amazolon; adamantan-1-amine hydrochloride; 1-Adamantylamine hydrochloride; Adamantanamine hydrochloride; Virofral; Influenol; Trivaline; Viregyt; Virasol; Amantan; Virosol; Adamantylamine hydrochloride; Aminoadamantane hydrochloride; Adamantine hydrochloride; 1-Adamantanamine, hydrochloride; NSC 83653; EXP 105-1; Tricyclodecane; Mantadix; Exp-105-1; Amantadine (hydrochloride); UN
Click to Show/Hide
|
|||
| Indication | Dyskinesia [ICD-11: MB47.4] | Phase 3 | [1] | |
| Company |
Adamas Pharmaceuticals Emeryville, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H18ClN
|
|||
| Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)N.Cl
|
|||
| InChI |
1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H
|
|||
| InChIKey |
WOLHOYHSEKDWQH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 665-66-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:2619
|
|||
| ADReCS Drug ID | BADD_D00098 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.